| Application number | Title of the application | Filing Date | Status |
|---|
| 09/496248 | Methods for treatment of restenosis using adenoviral vectors and transgene products | Feb 1, 2000 | Abandoned |
Array
(
[id] => 1181363
[patent_doc_number] => 06740794
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-25
[patent_title] => 'Methods of isolating the androgenic sex hormone from crustacean prawn and marine shrimp and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/494149
[patent_app_country] => US
[patent_app_date] => 2000-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 21647
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740794.pdf
[firstpage_image] =>[orig_patent_app_number] => 09494149
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/494149 | Methods of isolating the androgenic sex hormone from crustacean prawn and marine shrimp and methods of use | Jan 27, 2000 | Issued |
Array
(
[id] => 1167600
[patent_doc_number] => 06753139
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'Gene silencing'
[patent_app_type] => B1
[patent_app_number] => 09/491549
[patent_app_country] => US
[patent_app_date] => 2000-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9017
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753139.pdf
[firstpage_image] =>[orig_patent_app_number] => 09491549
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/491549 | Gene silencing | Jan 25, 2000 | Issued |
| 60/421108 | Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease | Jan 23, 2000 | Pending |
Array
(
[id] => 1521984
[patent_doc_number] => 06414218
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Mouse model for rheumatoid arthritis'
[patent_app_type] => B1
[patent_app_number] => 09/483897
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 31
[patent_no_of_words] => 4413
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/414/06414218.pdf
[firstpage_image] =>[orig_patent_app_number] => 09483897
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/483897 | Mouse model for rheumatoid arthritis | Jan 17, 2000 | Issued |
Array
(
[id] => 1534381
[patent_doc_number] => 06489141
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Nucleic acid sequence and methods for selectively expressing a protein in a target cell or tissue'
[patent_app_type] => B1
[patent_app_number] => 09/479645
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 89640
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489141.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479645
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479645 | Nucleic acid sequence and methods for selectively expressing a protein in a target cell or tissue | Jan 6, 2000 | Issued |
Array
(
[id] => 1335592
[patent_doc_number] => 06593139
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Initiation of full mammalian oocyte activation by multiple sperm components'
[patent_app_type] => B1
[patent_app_number] => 09/478848
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12058
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593139.pdf
[firstpage_image] =>[orig_patent_app_number] => 09478848
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/478848 | Initiation of full mammalian oocyte activation by multiple sperm components | Jan 6, 2000 | Issued |
Array
(
[id] => 7625612
[patent_doc_number] => 06723557
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-20
[patent_title] => 'Caenorhabditis elegans LOV-1 gene'
[patent_app_type] => B1
[patent_app_number] => 09/479467
[patent_app_country] => US
[patent_app_date] => 2000-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 44259
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723557.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479467
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479467 | Caenorhabditis elegans LOV-1 gene | Jan 5, 2000 | Issued |
Array
(
[id] => 7644069
[patent_doc_number] => 06428969
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Method for determining oncogenic activity of a substance'
[patent_app_type] => B1
[patent_app_number] => 09/473456
[patent_app_country] => US
[patent_app_date] => 1999-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9157
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/428/06428969.pdf
[firstpage_image] =>[orig_patent_app_number] => 09473456
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/473456 | Method for determining oncogenic activity of a substance | Dec 27, 1999 | Issued |
Array
(
[id] => 1597359
[patent_doc_number] => 06492575
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Method for developing transgenic mice'
[patent_app_type] => B1
[patent_app_number] => 09/242406
[patent_app_country] => US
[patent_app_date] => 1999-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7623
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492575.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242406
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242406 | Method for developing transgenic mice | Dec 27, 1999 | Issued |
| 09/471602 | PACKAGING CELLS | Dec 22, 1999 | Abandoned |
Array
(
[id] => 1508472
[patent_doc_number] => 06441156
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Calcium channel compositions and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/470443
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 45964
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441156.pdf
[firstpage_image] =>[orig_patent_app_number] => 09470443
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/470443 | Calcium channel compositions and methods of use thereof | Dec 21, 1999 | Issued |
Array
(
[id] => 1546754
[patent_doc_number] => 06444873
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'MSH5 ablated mice and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/469636
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 35
[patent_no_of_words] => 8672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444873.pdf
[firstpage_image] =>[orig_patent_app_number] => 09469636
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469636 | MSH5 ablated mice and uses therefor | Dec 21, 1999 | Issued |
Array
(
[id] => 4324239
[patent_doc_number] => 06331614
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Human CDC14A gene'
[patent_app_type] => 1
[patent_app_number] => 9/468872
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 33771
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331614.pdf
[firstpage_image] =>[orig_patent_app_number] => 468872
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/468872 | Human CDC14A gene | Dec 21, 1999 | Issued |
| 09/466139 | PROTEIN-PROTEIN INTERACTIONS IN NEURODEGENERATIVE DISORDERS | Dec 20, 1999 | Abandoned |
Array
(
[id] => 5890458
[patent_doc_number] => 20020013952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Self-contained system for sustained viral replication'
[patent_app_type] => new
[patent_app_number] => 09/460555
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14816
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013952.pdf
[firstpage_image] =>[orig_patent_app_number] => 09460555
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460555 | Self-contained system for sustained viral replication | Dec 13, 1999 | Issued |
| 60/287581 | BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE | Dec 13, 1999 | Pending |
Array
(
[id] => 6698330
[patent_doc_number] => 20030110524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'TRANSGENIC ORGANISMS AND THEIR USES'
[patent_app_type] => new
[patent_app_number] => 09/460559
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8470
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20030110524.pdf
[firstpage_image] =>[orig_patent_app_number] => 09460559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460559 | TRANSGENIC ORGANISMS AND THEIR USES | Dec 13, 1999 | Abandoned |
| 09/455367 | BETA PEPTIDE SCREENING ASSAY | Dec 2, 1999 | Abandoned |
Array
(
[id] => 1587309
[patent_doc_number] => 06359193
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Nucleotide sequences of lats genes'
[patent_app_type] => B1
[patent_app_number] => 09/442100
[patent_app_country] => US
[patent_app_date] => 1999-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 15
[patent_no_of_words] => 51549
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/359/06359193.pdf
[firstpage_image] =>[orig_patent_app_number] => 09442100
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/442100 | Nucleotide sequences of lats genes | Nov 16, 1999 | Issued |